Form 4: Cardlytics Director Scott A. Hill Acquires 40,000 Shares
SEC Form 4 Filing
Director Scott A. Hill purchased 40,000 shares of Cardlytics, Inc. (CDLX) at $3.58 per share on August 12, 2024.
Summary
- On August 12, 2024, Scott A. Hill, a director of Cardlytics, Inc. (CDLX), acquired 40,000 shares of common stock.
- The purchase price was $3.58 per share.
- Following the transaction, Mr. Hill directly owns 40,000 shares of Cardlytics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director buying shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It can be a positive signal, but should be considered alongside other factors.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of transaction: Scott A. Hill purchased 40,000 shares of Cardlytics (CDLX) at $3.58 per share. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.